These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34335822)

  • 61. Comparison of antiplatelet effect and safety of clopidogrel napadisilate with clopidogrel bisulfate in coronary artery disease patients: multi-center, randomized, double-blind, phase IV, non-inferiority clinical trial.
    Lee S; Lee HY; Park KW; Kang HJ; Koo BK; Kim HS; Choi DJ; Kim MA; Oh BH
    Am J Cardiovasc Drugs; 2013 Dec; 13(6):413-24. PubMed ID: 23913405
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Rationale and design of the SAFE-A study: SAFety and Effectiveness trial of Apixaban use in association with dual antiplatelet therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Hoshi T; Sato A; Nogami A; Gosho M; Aonuma K;
    J Cardiol; 2017 Apr; 69(4):648-651. PubMed ID: 27443596
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Relationship of Platelet Reactivity With Bleeding Outcomes During Long-Term Treatment With Dual Antiplatelet Therapy for Medically Managed Patients With Non-ST-Segment Elevation Acute Coronary Syndromes.
    Cornel JH; Ohman EM; Neely B; Jakubowski JA; Bhatt DL; White HD; Ardissino D; Fox KA; Prabhakaran D; Armstrong PW; Erlinge D; Tantry US; Gurbel PA; Roe MT
    J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27815268
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A randomized, double-blind, placebo- controlled study on the anti-haemostatic effects of Curcuma longa, Angelica sinensis and Panax ginseng.
    Fung FY; Wong WH; Ang SK; Koh HL; Kun MC; Lee LH; Li X; Ng HJ; Tan CW; Zhao Y; Linn YC
    Phytomedicine; 2017 Aug; 32():88-96. PubMed ID: 28732813
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparison of one-month versus twelve-month dual antiplatelet therapy after implantation of drug-eluting stents guided by either intravascular ultrasound or angiography in patients with acute coronary syndrome: rationale and design of prospective, multicenter, randomized, controlled IVUS-ACS and ULTIMATE-DAPT trial.
    Ge Z; Gao XF; Kan J; Kong XQ; Zuo GF; Ye F; Tian NL; Lin S; Liu ZZ; Shao YB; He YQ; Wen SY; Yang Q; Xia Y; Wang ZZ; Xiao PX; Li F; Zeng HS; Yang S; Wang Y; Tao L; Gao DS; Qu H; Qian XS; Han YL; Chen F; Zhang JJ; Chen SL
    Am Heart J; 2021 Jun; 236():49-58. PubMed ID: 33621541
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Rationale and design of the comparison between a P2Y12 inhibitor monotherapy versus dual antiplatelet therapy in patients undergoing implantation of coronary drug-eluting stents (SMART-CHOICE): A prospective multicenter randomized trial.
    Song YB; Oh SK; Oh JH; Im ES; Cho DK; Cho BR; Lee JY; Lee JM; Park TK; Yang JH; Choi JH; Choi SH; Lee SH; Gwon HC; Hahn JY
    Am Heart J; 2018 Mar; 197():77-84. PubMed ID: 29447787
    [TBL] [Abstract][Full Text] [Related]  

  • 67. An App-Based Intervention for Caregivers to Prevent Unintentional Injury Among Preschoolers: Cluster Randomized Controlled Trial.
    Ning P; Cheng P; Schwebel DC; Yang Y; Yu R; Deng J; Li S; Hu G
    JMIR Mhealth Uhealth; 2019 Aug; 7(8):e13519. PubMed ID: 31400105
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antiplatelet Efficacy of Fixed-Dose Aspirin-Clopidogrel Combination in Patients with Stable Coronary Artery Disease Treated with Drug-Eluting Stent Implantation.
    Lim S; Kim PJ; Baek C; Kim TH; Koh YS; Park HJ; Kim HY; Chang K; Chung WS; Seung KB
    Clin Drug Investig; 2015 Dec; 35(12):833-42. PubMed ID: 26507618
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Xuesaitong exerts long-term neuroprotection for stroke recovery by inhibiting the ROCKII pathway, in vitro and in vivo.
    Zhou D; Cen K; Liu W; Liu F; Liu R; Sun Y; Zhao Y; Chang J; Zhu L
    J Ethnopharmacol; 2021 May; 272():113943. PubMed ID: 33617967
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Elderly patients with acute coronary syndromes managed without revascularization: insights into the safety of long-term dual antiplatelet therapy with reduced-dose prasugrel versus standard-dose clopidogrel.
    Roe MT; Goodman SG; Ohman EM; Stevens SR; Hochman JS; Gottlieb S; Martinez F; Dalby AJ; Boden WE; White HD; Prabhakaran D; Winters KJ; Aylward PE; Bassand JP; McGuire DK; Ardissino D; Fox KA; Armstrong PW
    Circulation; 2013 Aug; 128(8):823-33. PubMed ID: 23852610
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Design and Methodology of a Multicenter Randomized Clinical Trial to Evaluate the Efficacy of Tongmai Jiangtang Capsules in Type 2 Diabetic Coronary Heart Disease Patients.
    Wang Y; Guo Y; Lei Y; Huang S; Dou L; Li C; Zhao B; Fu W; Zhou P; Wan H; Zhao M; Yang J
    Front Pharmacol; 2021; 12():625785. PubMed ID: 34149404
    [No Abstract]   [Full Text] [Related]  

  • 72. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).
    Park KW; Kang SH; Park JJ; Yang HM; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Chae IH; Kim HS
    JACC Cardiovasc Interv; 2013 Sep; 6(9):932-42. PubMed ID: 24050860
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Determination of the adequate dosage of rebamipide, a gastric mucoprotective drug, to prevent low-dose aspirin-induced gastrointestinal mucosal injury.
    Ota K; Takeuchi T; Nouda S; Ozaki H; Kawaguchi S; Takahashi Y; Harada S; Edogawa S; Kojima Y; Kuramoto T; Higuchi K
    J Clin Biochem Nutr; 2016 Nov; 59(3):231-237. PubMed ID: 27895392
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of endothelial dysfunction on residual platelet aggregability after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease.
    Fujisue K; Sugiyama S; Ono T; Matsuzawa Y; Akiyama E; Sugamura K; Matsubara J; Kurokawa H; Kaikita K; Iwashita S; Sumida H; Hokimoto S; Oniki K; Nakagawa K; Matsui K; Ogawa H
    Circ Cardiovasc Interv; 2013 Aug; 6(4):452-9. PubMed ID: 23922147
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Personalised antiplatelet therapy based on pharmacogenomics in acute ischaemic minor stroke and transient ischaemic attack: study protocol for a randomised controlled trial.
    Zhang XG; Zhu XQ; Xue J; Li ZZ; Jiang HY; Hu L; Yue YH
    BMJ Open; 2019 May; 9(5):e028595. PubMed ID: 31123001
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Personalized antiplatelet therapy guided by a novel detection of platelet aggregation function in stable coronary artery disease patients undergoing percutaneous coronary intervention: a randomized controlled clinical trial.
    Zheng YY; Wu TT; Yang Y; Hou XG; Gao Y; Chen Y; Yang YN; Li XM; Ma X; Ma YT; Xie X
    Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(4):211-221. PubMed ID: 31603191
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mingjing granule, a traditional Chinese medicine in the treatment of neovascular age-related macular degeneration: study protocol for a randomized controlled trial.
    Li Y; Liang L; Snellingen T; Xu K; Gao Y; Zhang F; Guo C; Zuo T; Liang F; Yao X; Yang X
    Trials; 2021 Jan; 22(1):69. PubMed ID: 33468208
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Thrombelastographic haemostatic status and antiplatelet therapy after coronary artery bypass surgery (TEG-CABG trial): assessing and monitoring the antithrombotic effect of clopidogrel and aspirin versus aspirin alone in hypercoagulable patients: study protocol for a randomized controlled trial.
    Rafiq S; Johansson PI; Zacho M; Stissing T; Kofoed K; Lilleør NB; Steinbrüchel DA
    Trials; 2012 Apr; 13():48. PubMed ID: 22540524
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial.
    Bath PM; Woodhouse LJ; Appleton JP; Beridze M; Christensen H; Dineen RA; Duley L; England TJ; Flaherty K; Havard D; Heptinstall S; James M; Krishnan K; Markus HS; Montgomery AA; Pocock SJ; Randall M; Ranta A; Robinson TG; Scutt P; Venables GS; Sprigg N;
    Lancet; 2018 Mar; 391(10123):850-859. PubMed ID: 29274727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.